Rob is a Research Associate with more than 12 years of research experience in malaria. His core research interests focus on understanding the biology underlying novel antimalarial drug targets and mechanisms of drug resistance using a range of cell physiology, biochemistry and molecular genetics techniques. His current research focuses on the Plasmodium falciparum acetyl CoA synthetase (PfAcAS), a novel drug target implicated in protein acetylation and the epigenetic regulation of gene expression.
